Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues
- 2k Downloads
Recently, those substances deriving from the active ingredient of the Khat plant, cathinone, have been rising in popularity. Indeed, 4-methylmethcathinone (mephedrone; ‘meow meow’ and others) has been seen by some as a cheaper alternative to other classified recreational drugs.
We aimed here at providing a state-of-the-art review on mephedrone history and prevalence of misuse, chemistry, pharmacology, legal status, product market appearance, clinical/management and related fatalities.
Because of the limited evidence, some of the information here presented has been obtained from user reports/drug user-orientated web sites. The most common routes for mephedrone recreational use include insufflation and oral ingestion. It elicits stimulant and empathogenic effects similar to amphetamine, methylamphetamine, cocaine and MDMA. Due to its sympathomimetic actions, mephedrone may be associated with a number of both physical and psychopathological side effects. Recent preliminary analysis of recent UK data carried out in 48 related cases have provided positive results for the presence of mephedrone at postmortem.
Discussion and Conclusions
Within the UK, diffusion of mephedrone may have been associated with an unprecedented combination of a particularly aggressive online marketing policy and a decreasing availability/purity of both ecstasy and cocaine. Mephedrone has been recently classified in both the UK and in a number of other countries as a measure to control its availability. Following this, a few other research psychoactives have recently entered the online market as yet unregulated substances that may substitute for mephedrone. Only international collaborative efforts may be able to tackle the phenomenon of the regular offer of novel psychoactive drugs.
KeywordsMephedrone Meow meow Cathinones Drug misuse Drug-related deaths Psychoactive drugs
The present study was carried out with the support of the European Commission (EC); e.g. for both the Psychonaut Web Mapping System (A/800102; 2006 348) and the ReDNet (EC Executive Agency for Health and Consumers in the framework of the Public Health Programme; 2009 12 26) projects. The views expressed here reflect only the authors’ views and not necessarily those of the relevant EC officers.
Conflict of interest
No conflicts of interest are declared here which may have influenced the interpretation of present data.
- Advisory Council on the Misuse of Drugs/ACMD (2010) Advisory Council on the Misuse of Drugs on Consideration of the Cathinones. http://www.homeoffice.gov.uk/publications/drugs/acmd1/acmd-cathinodes-report-2010, accessed 18 August 2010
- Brunt TM, Poortman A, Niesink RJ, van den Brink W (2010) Instability of the ecstasy market and a new kid on the block: mephedrone. J Psychopharmacol (Sep 8, in press)Google Scholar
- Camilleri A, Johnston MR, Brennan M, Davis S, Caldicott DG (2010) Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, alpha-phthalimidopropiophenone and N-ethylcathinone. Forensic Sci Int 197:59–66PubMedCrossRefGoogle Scholar
- Campbell D (2009) Online sales of legal alternatives to class A drugs raise safety fears. http://www.guardian.co.uk/society/2009/mar/12/online-legal-drugs-stimulants, accessed 19 August 2010
- Chemicalbook (2010) http://www.chemicalbook.com, accessed 21 March 2010
- Chemspider (2010) http://www.chemspider.com, accessed 21 March 2010
- Corazza O, Davey Z, Deluca P, Demetrovics Z, Drummond C, Enea A, Moskalewicz J, Di Melchiorre G, Di Furia L, Farre' M, Flesland L, Scherbaum N, Siemann H, Skutle A, Torrens M, Pasinetti M, Pezzolesi C, Shapiro H, Sferrazza E, van der Kreeft P, Schifano F (2010) Le potenzialità della prevenzione digitale in materia di nuove droghe: il ruolo del Recreational Drugs European Network-ReDNet [Potential of digital prevention relating to novel drugs’ misuse: the role of the Recreational Drugs European Network-ReDNet] Dipend Patol (in press)Google Scholar
- Daly M (2010) Teenage kicks. http://www.drugscope.org.uk/Resources/Drugscope/Documents/PDF/Good%20Practice/DruglinkJanFeb10.pdf, accessed 19 August 2010
- Deluca P, Schifano F, Davey Z, Corazza O, Di Furia L, and the Psychonaut Web Mapping Research Group (2009). Mephedrone Report. Institute of Psychiatry, King’s College London, London (UK), 2009. www.psychonautproject.eu, accessed 19 August 2010
- Drugsforum (2010) http://www.drugs-forum.com, accessed 17 April 2010
- Europol–EMCDDA joint report on a new psychoactive substance: 4-methylmethcathinone (mephedrone). http://www.emcdda.europa.eu/attachements.cfm/att_102496_EN_Europol-EMCDDA_Joint_Report_Mephedrone.pdf, accessed 16 August 2010
- Financiarul online (2010): Salvia divinorum, psilocybe mushrooms are among hallucinogenic herbs banned by gov’t. http://www.financiarul.ro/?s=Salvia+divinorum%2C+psilocybe+mushrooms+are+among+hallucinogenic+herbs+banned+by+gov%E2%80%99t+, accessed 18 August 2010
- Fleming N (2010) Miaow-miaow on trial: truth or trumped-up charges? http://www.newscientist.com/article/dn18712-miaowmiaow-on-trial-truth-or-trumpedup-charges.html, accessed 19 August 2010
- Freepressindex (2010) Get mephedrone very easily. Posted on March 16, 2010. http://www.freepressindex.com/news-get-mephedrone-very-easily-17851.html, accessed 19 August 2010
- Ghodse AH, Corkery J, Oyefeso A, Schifano F, Ahmed K, Naidoo V (2010) Drug related deaths in the UK. Annual Report 2010. International Centre for Drug Policy, St George's, University of London, UKGoogle Scholar
- Gustaffsson D, Escher C (2009) Mefedron. Internetdrog som tycks ha kommit för att stanna [Mephedrone—Internet drug that seems to have come to stay]. Lakartidningen 106:2769–2771Google Scholar
- Hand T, Rishiraj A (2009) Seizures of drugs in England and Wales 2008/09. Home Office Statistical Bulletin 16/09. Home Office, LondonGoogle Scholar
- James D, Adams RD, Spears R, Cooper G, Lupton DJ, Thompson JP, Thomas SH; on behalf of the National Poisons Information Service (2010) Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service. Emerg Med J (Aug 25, in press)Google Scholar
- Lee WS, Chan MF, Tam WM, Hung MY (2007) The application of capillary electrophoresis for enantiomeric separation of N,N-dimethylamphetamine and its related analogs: intelligence study on N,N-dimethylamphetamine samples in crystalline and tablet forms. Forensic Sci Int 165:71–77PubMedCrossRefGoogle Scholar
- Mephedrone.com (2010) http://www.mephedrone.com, accessed 15 March 2010 and 20 August 2010)
- Mephedrone2you (2010) http://www.mephedrone2u.com/, accessed 20 August 2010
- Meyer MR, Wilhelm J, Peters FT, Maurer HH (2010) Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry. Anal Bioanal Chem 397:1225–1233PubMedCrossRefGoogle Scholar
- National Treatment Agency (2010) Drug treatment in 2009–2010. www.nta.nhs.uk, accessed 8 October 2010
- Newcombe R (2009) Mephedrone: the use of mephedrone (M-cat, meow) in Middlesbrough. Lifeline Pubblications, ManchesterGoogle Scholar
- ABC News (2008) Police warn of potentially fatal 'fake ecstasy'. http://www.abc.net.au/news/stories/2008/06/17/2277735.htm, accessed 19 August 2010
- BBC News (2009) Call for ban on 'legal high' drug. http://news.bbc.co.uk/1/hi/health/8023451.stm, accessed 19 August 2010
- Odenwald M, Neuner F, Schauer M, Elbert T, Catani C, Lingenfelder B, Hinkel H, Häfner H, Rockstroh B (2005) Khat use as risk factor for psychotic disorders: a cross-sectional and case–control study in Somalia. BMC Med 12:3–5Google Scholar
- Power M (2009) Mephedrone: the future of drug dealing. http://www.drugscope.org.uk/Resources/Drugscope/Documents/PDF/Good%20Practice/Druglink_March_09_mephedrone.pdf, accessed 19 August 2010
- Power M (2010) How mephedrone shook the drug trade. http://www.drugscope.org.uk/Resources/Drugscope/Documents/PDF/Good%20Practice/DruglinkJanFeb10.pdf, accessed 19 August 2010
- Pubchem (2010). http://pubchem.ncbi.nlm.nih.gov, accessed 21 March 2010
- Roussel O, Perrin M, Herard P, Chevance M, Arpino P (2009) La 4-méthyléphédrone sera-t-elle une "Ecstasy" du XXIème siècle? Ann Toxicol Anal 21:169–177Google Scholar
- Saem de Burnaga Sanchez J (1929) Sur un homologue de l’ephedrine. Bull Soc Chim Fr 45:284–286Google Scholar
- Schifano F, Deluca P, Baldacchino A, Peltoniemi T, Scherbaum N, Torrens M, Farre’ M, Flores I, Rossi M, Eastwood D, Guionnet C, Rawaf S, Agosti L, Di Furia L, Brigada R, Majava A, Siemann H, Leoni M, Tomasin A, Rovetto F, Ghodse AH, Psychonaut 2002 Research Group (2006) Drugs on the web: the Psychonaut 2002 EU project. Progr Neuropsychopharmacol Biol Psychiatry 30:640–646CrossRefGoogle Scholar
- Schmidt MM, Sharma A, Schifano F, Feinmann C (2010) Legal highs on the net: evaluation of UK based websites, products and product information. Forensic Sci Int (Jul 20, in press)Google Scholar
- Sumnall H, Wooding O (2009) Mephedrone: an update on current knowledge. Centre for Public Health, Liverpool John Moores University. http://www.drugsandalcohol.ie/12762/, accessed 19 August 2010
- Townsend M (2010) New drug set to replace banned mephedrone as a ‘legal high’. http://www.guardian.co.uk/society/2010/apr/18/drug-replace-ban-mephedrone, accessed 19 August 2010
- Urquhart C. (2004): Drugs and dance as Israelis blot out intifada. http://www.guardian.co.uk/world/2004/sep/04/israel, accessed 18 August 2010
- Winstock A, Mitcheson L, Deluca P, Davey Z, Corazza O, Schifano F (2010b) Mephedrone; new kid for the chop. Addiction (August 23rd, in press)Google Scholar